Haruaki Shirakawa

Summary

Affiliation: Shinshu University
Country: Japan

Publications

  1. ncbi Laparoscopic findings in patients with nonalcoholic steatohepatitis
    Naoki Tanaka
    Division of Gastroenterology, Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan
    Liver Int 26:32-8. 2006
  2. ncbi Useful parameters for distinguishing nonalcoholic steatohepatitis with mild steatosis from cryptogenic chronic hepatitis in the Japanese population
    Naoki Tanaka
    Division of Gastroenterology, Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan
    Liver Int 26:956-63. 2006
  3. ncbi Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor alpha in transgenic mice: implications for HCV-associated hepatocarcinogenesis
    Naoki Tanaka
    Department of Metabolic Regulation, Institute on Aging and Adaptation, Shinshu University Graduate School of Medicine, Matsumoto, Japan
    Int J Cancer 122:124-31. 2008
  4. pmc PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice
    Naoki Tanaka
    Department of Metabolic Regulation, Institute on Aging and Adaptation, Shinshu University Graduate School of Medicine, Matsumoto, Nagano, Japan
    J Clin Invest 118:683-94. 2008
  5. doi Insulin resistance and hepatitis C virus: a case-control study of non-obese, non-alcoholic and non-steatotic hepatitis virus carriers with persistently normal serum aminotransferase
    Naoki Tanaka
    Department of Metabolic Regulation, Shinshu University Graduate School of Medicine, Matsumoto, Japan
    Liver Int 28:1104-11. 2008
  6. doi Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors
    Haruaki Shirakawa
    Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan
    Hepatology 48:1753-60. 2008
  7. doi De novo autoimmune hepatitis following living-donor liver transplantation for primary biliary cirrhosis
    Kaname Yoshizawa
    Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan
    Clin Transplant 22:385-90. 2008

Collaborators

Detail Information

Publications7

  1. ncbi Laparoscopic findings in patients with nonalcoholic steatohepatitis
    Naoki Tanaka
    Division of Gastroenterology, Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan
    Liver Int 26:32-8. 2006
    ..However, the laparoscopic findings of nonalcoholic steatohepatitis (NASH) have not been characterized. The aim of this study was to clarify the laparoscopic characteristics of NASH...
  2. ncbi Useful parameters for distinguishing nonalcoholic steatohepatitis with mild steatosis from cryptogenic chronic hepatitis in the Japanese population
    Naoki Tanaka
    Division of Gastroenterology, Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan
    Liver Int 26:956-63. 2006
    ..We aimed to test this possibility and to isolate factors that may indicate NASH...
  3. ncbi Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor alpha in transgenic mice: implications for HCV-associated hepatocarcinogenesis
    Naoki Tanaka
    Department of Metabolic Regulation, Institute on Aging and Adaptation, Shinshu University Graduate School of Medicine, Matsumoto, Japan
    Int J Cancer 122:124-31. 2008
    ....
  4. pmc PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice
    Naoki Tanaka
    Department of Metabolic Regulation, Institute on Aging and Adaptation, Shinshu University Graduate School of Medicine, Matsumoto, Nagano, Japan
    J Clin Invest 118:683-94. 2008
    ..Thus, our results indicate that persistent activation of PPARalpha is essential for the pathogenesis of hepatic steatosis and HCC induced by HCV infection...
  5. doi Insulin resistance and hepatitis C virus: a case-control study of non-obese, non-alcoholic and non-steatotic hepatitis virus carriers with persistently normal serum aminotransferase
    Naoki Tanaka
    Department of Metabolic Regulation, Shinshu University Graduate School of Medicine, Matsumoto, Japan
    Liver Int 28:1104-11. 2008
    ..Therefore, we aimed at exploring the singular effects of HCV on glucose metabolism through analysis of HCV carriers with persistently normal serum aminotransferase...
  6. doi Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors
    Haruaki Shirakawa
    Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan
    Hepatology 48:1753-60. 2008
    ..In conclusion, a logistic regression model that includes the sequence of ISDR of the HCV, Th1/Th2 ratio, body weight, and neutrophil count can be useful for accurately predicting actual SVR rate before combination therapy...
  7. doi De novo autoimmune hepatitis following living-donor liver transplantation for primary biliary cirrhosis
    Kaname Yoshizawa
    Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan
    Clin Transplant 22:385-90. 2008
    ..In conclusion, recipient immune cells attacked the allogeneic transplanted liver of the patient via de novo AIH, although the exact participation of autoimmune mechanisms is unclear...